Glycorex Signs Distribution Agreement in Malaysia
Glycorex Transplantation AB has entered into a distribution agreement with Malaysia-based OneMedik (M) SDN BHD. The deal expands the market access for Glycorex's Glycosorb® ABO product.

Glycorex Transplantation AB (publ) is expanding its international reach through a new distribution agreement with OneMedik (M) SDN BHD in Malaysia. This partnership will introduce Glycorex's Glycosorb® ABO product to the Malaysian market.
OneMedik (M) SDN BHD specializes in distributing medical devices for plasmapheresis and has operated in Malaysia since 2009. The company collaborates with local healthcare providers to supply essential medical technology across the region.
The agreement targets a significant market where 70% of kidney transplants utilize living donors. Glycorex's technology is considered particularly suitable for these types of transplant procedures.
This move is part of Glycorex's broader strategy to increase its global presence and make its products available in new territories.